Vaginal microbicides may benefit men more than women, study shows

Vaginal microbicides may benefit men more than women, study shows
Researchers also say clinical-trial design may mask risk of drug resistance

By Enrique Rivero

Vaginal microbicides currently in clinical trials may be the only weapon that will protect women against infection from HIV. Yet, under likely circumstances, these microbicides may be of more benefit to men than women, according to a new UCLA AIDS Institute study.

The study, which used novel mathematical models to simulate clinical trials and population-level transmission of HIV, appears July 7 in the online issue of Proceedings of the National Academy of Sciences.

Treadmill training helps Down syndrome babies walk months earlier

Treadmill training helps Down syndrome babies walk months earlier

ANN ARBOR, Michigan— La instrucción con la "cinta de caminata" a los niños con síndrome de Down, aunque sea por unos pocos minutos cada día, puede ayudarles a que camine de cuatro a cinco meses antes que lo esperado con la terapia física tradicional, y sugiere que los infantes que tienen una instrucción intensa en la correa podrían caminar aún más pronto.

Ver VIDEO